ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 125 filers reported holding ACORDA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $37,000 | -35.1% | 18,342 | -7.7% | 0.27% | +171.4% |
| Q3 2019 | $57,000 | -72.1% | 19,878 | +51.7% | 0.10% | -61.6% |
| Q4 2018 | $204,000 | -71.5% | 13,101 | -64.0% | 0.26% | -53.6% |
| Q3 2018 | $716,000 | -9.9% | 36,416 | +31.4% | 0.55% | -14.5% |
| Q2 2018 | $795,000 | -27.5% | 27,704 | -40.2% | 0.64% | -45.8% |
| Q1 2018 | $1,096,000 | -4.4% | 46,337 | -13.3% | 1.18% | -10.3% |
| Q4 2017 | $1,146,000 | -19.1% | 53,442 | -10.7% | 1.32% | -1.7% |
| Q3 2017 | $1,416,000 | +50.5% | 59,866 | +25.4% | 1.34% | +6.2% |
| Q2 2017 | $941,000 | +217.9% | 47,752 | +326.7% | 1.26% | +162.2% |
| Q1 2016 | $296,000 | -75.2% | 11,190 | -59.9% | 0.48% | -75.4% |
| Q4 2015 | $1,195,000 | +103.6% | 27,932 | +26.2% | 1.96% | +121.0% |
| Q3 2015 | $587,000 | -9.7% | 22,136 | +13.5% | 0.89% | -3.0% |
| Q2 2015 | $650,000 | +68.4% | 19,498 | +68.2% | 0.91% | +57.3% |
| Q1 2015 | $386,000 | -69.7% | 11,594 | -62.8% | 0.58% | +11.7% |
| Q4 2014 | $1,274,000 | +34.1% | 31,163 | +11.1% | 0.52% | +49.9% |
| Q3 2014 | $950,000 | -11.7% | 28,054 | -1.2% | 0.35% | +75.3% |
| Q1 2014 | $1,076,000 | – | 28,385 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|